COMMUNIQUÉS West-GlobeNewswire

Annual General and Special Meeting of Shareholders to be held May 7, 2026
21/04/2026
TORONTO, April 21, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and [...]
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
21/04/2026
Oral presentation will include previously announced topline results as well as pre-specified and post-hoc data updates REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” [...]
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development
21/04/2026
CHICAGO, April 21, 2026 (GLOBE NEWSWIRE) -- One of the most fundamental questions in biology is how a single fertilized egg produces the diverse cell types making up the body – from neurons and skin to muscle and blood [...]
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
21/04/2026
Results showed lasofoxifene protected against hormone withdrawal-induced bone loss and maintained a robust anti-tumor response in primary and metastatic animal models of ER+ breast cancer BOTHELL, Wash., April 21, 2026 [...]
BPGbio Appoints Former Oxford Pro-Vice Chancellor for Innovation Chas Bountra, Ph.D., as Executive Vice President and Chief Scientific Officer
21/04/2026
• Former Oxford Pro-Vice-Chancellor for Innovation and former Head of Biology at GSK to lead company’s R&D • Longstanding Scientific Advisory Board Chair steps into an expanded leadership role to accelerate the [...]
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
21/04/2026
Two oral presentations including late-breaker at SID Data will cover Phase 1 clinical trial of soquelitinib for atopic dermatitis, including new immunologic and biomarker data supporting drug-free remissions Investor [...]
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
21/04/2026
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
21/04/2026
New in vivo data demonstrate exceptional selectivity, localization and potency of MDNA113 in the tumor and tumor microenvironment while enhancing the systemic tolerability profile Head-to-head non-human primate [...]
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
21/04/2026
This is the first release of 36-week symptom response & tissue health data for the highest dose (Cohort 9) from the dose escalation portion of Eupraxia’s RESOLVE trial. At 36 weeks, patients in Cohort 9 (n=3) [...]
Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety
21/04/2026
BEIJING, April 21, 2026 (GLOBE NEWSWIRE) -- At the 2026 American Association for Cancer Research (AACR) Annual Meeting, InnoCare Pharma (HKEX: 9969; SSE: 688428) presented preclinical data of its novel B7-H3 targeted [...]
RAMSAY SANTE : mise à disposition du rapport financier semestriel au 31 décembre 2025
21/04/2026
Paris, le 21 avril 2026 RAMSAY SANTE Mise à disposition du rapport financier semestriel au 31 décembre 2025 Ce document est disponible sur le site internet de RAMSAY SANTE : http://www.ramsaysante.fr À propos de Ramsay [...]
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models
21/04/2026
Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line models Immune cells activated by Bria-OTS+ exhibit serial killing activity across multiple [...]
Dark Horse Consulting Group’s Acquisition of CJ PARTNERS Provides Regional Expansion
21/04/2026
WALNUT CREEK, Calif. and TOKYO, April 21, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”) today announced the acquisition of CJ PARTNERS (“CJP”), a distinguished consulting and advisory firm [...]
RAMSAY SANTE : Half-year Financial Report as at end of December 2025 disposal
21/04/2026
Paris, April 21, 2026 RAMSAY SANTE Half-year Financial Report as at end of December 2025 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé Ramsay Santé is [...]
Transactions in connection with share buy-back program
21/04/2026
Company announcement no. 11 - 26 21 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Grady Manual Therapy Ltd Champions "Exercise is Medicine" to Deliver Professional Sports Health Care to Everyday Athletes in Hong Kong
21/04/2026
HONG KONG, April 21, 2026 (GLOBE NEWSWIRE) -- Grady Manual Therapy Ltd today highlighted its ongoing mission to provide professional-grade sports health care and emergency field support to non-occupational athletes. [...]
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
21/04/2026
First public disclosure of the chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16-dependent Targeted Glue™ degrader of BRD9 AMX-883 is the Company’s lead asset entering a Phase I [...]
Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows
21/04/2026
Elevating the importance of neural health via better diagnosis and treatment is crucial for restoration of natural hearing, JARO review concludes Sheffield, UK, April 21, 2026 (GLOBE NEWSWIRE) -- The role of neural [...]
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
21/04/2026
CE mark awarded for aXess™ at record speed, underpinned by strong EU pivotal trial data Xeltis advances ahead of schedule to commercialization aXess™ reduces the need for vascular access interventions enabling more [...]

Pages